AVE 0991, a non‐peptide mimic of angiotensin‐(1–7) effects, attenuates pulmonary remodelling in a model of chronic asthma
British Journal of Pharmacology2013Vol. 170(4), pp. 835–846
Citations Over TimeTop 10% of 2013 papers
M G Rodrigues‐Machado, Giselle Santos Magalhães, J A Cardoso, Lucas M. Kangussu, A Murari, Marcelo Vidigal Caliari, Marilene L. Oliveira, Denise Carmona Cara, M L M Noviello, Fúlvia D. Marques, Jousie Michel Pereira, Roberto Queiroga Lautner, Robson A.S. Santos, Maria José Campagnole‐Santos
Abstract
AVE treatment prevented pulmonary remodelling, inflammation and right ventricular hypertrophy in OVA mice, suggesting that Ang-(1-7) receptor agonists are a new possibility for the treatment of pulmonary remodelling induced by chronic asthma.
Related Papers
- → Changes in the shape and surface hydrophobicity of ovalbumin during its transformation to s-ovalbumin.(1981)31 cited
- → Effects of limited proteolysis on functional properties of ovalbumin(1987)31 cited
- → Changes in the Heat-induced Gelling Properties of Ovalbumin during Its Conversion to s-Ovalbumin(1984)11 cited
- → Studies on ovalbumin-s-ovalbumin transformation. Part IV. Changes in the heat-induced gelling properties of ovalbumin during its conversion to s-ovalbumin.(1984)8 cited